Name | Title | Contact Details |
---|---|---|
Bernard Becker |
Vice President and Chief Human Resources Officer | Profile |
eTherapi is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Home Instead Senior Care® network is the world`s leading provider of personalized in-home care services. We have over 1,100 independently owned and operated franchise offices worldwide that employ compassionate CAREGivers who share our dedication to enhancing the lives of aging adults and their families. Services span the care continuum, from companionship and personal care to specialized Alzheimer`s care and hospice support. Caring for others is part of our DNA, and that includes caring for your career. The Home Instead Senior Care network provides best-in-class training, education, and opportunities for career advancement. It also offers you the opportunity to be part of a supportive family-like culture where you`re encouraged to talk with your local office for support, share stories, and seek guidance.
Triad Healthcare Inc. is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Triad Healthcare Inc. is based in Plainville, CT. You can find more information on Triad Healthcare Inc. at www.triadhealthcareinc.com
SciMar is a Winnipeg, MB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Kite Pharma, founded in 2009, is dedicated to the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to fight tumor cells. Kite’s lead programs are in collaboration with the National Cancer Institute (NCI) and are being studied through the NCI’s Surgery Branch led by Steven A. Rosenberg, MD, PhD, who has pioneered immunotherapy approaches for cancer for more than two decades. This research has resulted in breakthrough clinical findings, including results from an NCI Phase 1/2a trial being presented at this year’s American Society of Hematology (ASH) Annual Meeting. Based on this progress and momentum, Kite plans to initiate a company-sponsored multicenter clinical program in aggressive non-Hodgkin’s lymphoma, with additional filings expected for other eACT™ products in diverse oncology indications.